Replies to post #340010 on Innovation Pharmaceuticals Inc (IPIX)

[Jhawker]

Good catch. Looks like the sun man is wrong again!

[Minnesinger]

An argument could be made...

that the Seqens article published in early December was written to, in part, address this stipulation.

When sponsors receive an expedited drug development designation, they should be prepared to propose a commercial manufacturing program that will ensure availability of quality product at the time of approval. The proposal should consider estimated market demand and the commercial manufacturing development plan.

https://www.pharmasalmanac.com/articles/the-importance-of-a-global-leader-in-small-molecule-manufacturing-during-the-covid-19-pandemic

[JTORENCE]

'LilKahuna'those requirements are going to handcuff LEO if he doesn't start hiring people who are familiar with process. A 3 man operation ain't gonna cut it. imo

[LilyGDog]

Thanks LilKahuna! There is a lot of potential for the company who will be manufacturing Brilacidin for covid.

Go Leo & IPIX!

“ The sponsor of a product that receives an expedited drug development designation may need to pursue a more rapid manufacturing development program to accommodate the accelerated pace of the clinical program. The sponsor’s product quality and CMC teams should initiate early communication with FDA to ensure that the manufacturing development programs and timing of submissions meet the Agency’s expectations for licensure or marketing approval.40
When sponsors receive an expedited drug development designation, they should be prepared to propose a commercial manufacturing program that will ensure availability of quality product at the time of approval. The proposal should consider estimated market demand and the commercial manufacturing development plan. The proposal should also consider manufacturing facilities and a lifecycle approach to process validation. Additionally, the proposal should include a timeline for development of the manufacturing capabilities with goals aligned with the clinical development program. After the initial discussion following designation, frequent communication during development will generally facilitate meeting manufacturing development goals and product quality goals.”

—Expedited Review, A. Manufacturing and Product Quality Considerations, p. 25
https://www.fda.gov/media/86377/download

[attilathehunt]

"When sponsors receive an expedited drug development designation, they should be prepared to propose a commercial manufacturing program that will ensure availability of quality product at the time of approval. The proposal should consider estimated market demand and the commercial manufacturing development plan."


This should alleviate the questions around the current dilution.